5-LOX and leukotrienes appear to be relevant therapeutic targets for lung chemoprevention based on the findings of higher levels of 5-LOX metabolites in a number of human solid tumors, including lung cancer and leukemias, compared to normal tissues [10]. Here, ALOX5 is linked to lung carcinoma.